BDBM182797 US9145414, 160

SMILES N[C@H]1COCC[C@H]1Nc1nnc(C(N)=O)c(Nc2cccc3n(ccc23)C2CC2)n1

InChI Key InChIKey=CSGWYPONEHTTTJ-DZGCQCFKSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 182797   

TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM182797(US9145414, 160)
Affinity DataIC50:  0.380nMpH: 7.5 T: 2°CAssay Description:The in vitro inhibitory activity of the compound of the present invention against Syk kinase activity was assayed under the following conditions: the...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase B(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM182797(US9145414, 160)
Affinity DataIC50:  1.30E+3nMpH: 7.4 T: 2°CAssay Description:The in vitro inhibitory activity of the compound against Aurora B kinase activity was assayed with reference to a method described in patent publicat...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM182797(US9145414, 160)
Affinity DataIC50:  1.40E+3nMpH: 7.5Assay Description:Conditions for assaying the in vitro inhibitory activity of the compound against KDR kinase activity were set with reference to the statement in the ...More data for this Ligand-Target Pair
In DepthDetails US Patent